# Elutia Inc.: filings

ELUT · Nasdaq · CIK 1708527 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/elut.md) · [Financials](/companies/elut/financials.md) · [Filings](/companies/elut/filings.md) · [Insiders](/companies/elut/insiders.md)

## Reports and events: 124 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 141, 8-K 85, 10-Q 18, 3 18, SC 13G/A 9, SCHEDULE 13G/A 8, CORRESP 7, 10-K 6, 424B5 6, D 6, DEF 14A 6, DEFA14A 6, SC 13G 6, UPLOAD 6, EFFECT 5, S-3 4, S-8 4, 424B3 3, 4/A 3, SC 13D/A 3, SCHEDULE 13G 3, ARS 2, SCHEDULE 13D/A 2, 144 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 17:00 ET | [8-K](/filings/0001104659-26-099731.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-099731 |
| 2026-08-14 | 16:45 ET | [10-Q](/filings/0001104659-26-097292.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097292 |
| 2026-08-13 | 16:15 ET | [8-K](/filings/0001104659-26-095934.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095934 |
| 2026-08-07 | 16:15 ET | [8-K](/filings/0001104659-26-092718.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-26-092718 |
| 2026-07-20 | 16:06 ET | [8-K](/filings/0001104659-26-085061.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-085061 |
| 2026-06-16 | 17:00 ET | [8-K](/filings/0001104659-26-074660.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-074660 |
| 2026-05-15 | 16:31 ET | [10-Q](/filings/0001104659-26-062634.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062634 |
| 2026-05-14 | 16:06 ET | [8-K](/filings/0001104659-26-061150.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-061150 |
| 2026-04-22 | 17:00 ET | [DEF 14A](/filings/0001104659-26-046897.md) | Proxy statement, period 2026-06-11 | 0001104659-26-046897 |
| 2026-03-13 | 16:11 ET | [10-K](/filings/0001104659-26-027664.md) | Annual report, period 2025-12-31 | 0001104659-26-027664 |
| 2026-03-11 | 16:15 ET | [8-K](/filings/0001104659-26-026398.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-026398 |
| 2026-03-09 | 17:00 ET | [8-K](/filings/0001104659-26-025311.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-025311 |
| 2026-03-04 | 08:00 ET | [8-K](/filings/0001104659-26-023189.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023189 |
| 2026-01-12 | 08:51 ET | [8-K](/filings/0001104659-26-002742.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-002742 |
| 2026-01-02 | 08:45 ET | [8-K](/filings/0001104659-26-000076.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-26-000076 |
| 2025-12-15 | 16:07 ET | [SCHEDULE 13D/A](/filings/0001104659-25-121122.md) | Ownership report, active investor, amended | 0001104659-25-121122 |
| 2025-11-12 | 17:01 ET | [10-Q](/filings/0001104659-25-110492.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110492 |
| 2025-11-12 | 07:00 ET | [8-K](/filings/0001104659-25-109699.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-109699 |
| 2025-11-06 | 16:15 ET | [8-K](/filings/0001104659-25-107741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107741 |
| 2025-10-14 | 17:01 ET | [8-K](/filings/0001104659-25-099347.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-099347 |
| 2025-10-07 | 17:00 ET | [8-K](/filings/0001104659-25-097561.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-097561 |
| 2025-09-09 | 09:00 ET | [8-K](/filings/0001104659-25-088481.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-088481 |
| 2025-08-20 | 16:15 ET | [8-K](/filings/0001104659-25-080916.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-080916 |
| 2025-08-14 | 17:00 ET | [10-Q](/filings/0001558370-25-011590.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011590 |
| 2025-08-14 | 16:11 ET | [8-K](/filings/0001104659-25-078596.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078596 |
| 2025-06-04 | 17:00 ET | [8-K](/filings/0001558370-25-008401.md) | 5.07 Shareholder vote results | 0001558370-25-008401 |
| 2025-05-13 | 16:50 ET | [10-Q](/filings/0001558370-25-007586.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007586 |
| 2025-05-08 | 16:25 ET | [8-K](/filings/0001104659-25-046155.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-046155 |
| 2025-05-06 | 16:15 ET | [8-K](/filings/0001104659-25-045050.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-045050 |
| 2025-04-04 | 17:00 ET | [DEF 14A](/filings/0001104659-25-032259.md) | Proxy statement, period 2025-05-29 | 0001104659-25-032259 |
| 2025-03-13 | 16:32 ET | [SCHEDULE 13D/A](/filings/0001104659-25-023499.md) | Ownership report, active investor, amended | 0001104659-25-023499 |
| 2025-03-11 | 17:00 ET | [10-K](/filings/0001558370-25-002719.md) | Annual report, period 2024-12-31 | 0001558370-25-002719 |
| 2025-03-06 | 16:13 ET | [8-K](/filings/0001104659-25-021371.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-021371 |
| 2025-02-04 | 17:14 ET | [8-K](/filings/0001104659-25-009187.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009187 |
| 2025-02-03 | 06:07 ET | [8-K](/filings/0001104659-25-008297.md) | 2.02 Results of operations; 8.01 Other events | 0001104659-25-008297 |
| 2024-11-14 | 17:00 ET | [10-Q](/filings/0001558370-24-015748.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015748 |
| 2024-11-14 | 16:10 ET | [8-K](/filings/0001104659-24-118906.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118906 |
| 2024-10-03 | 16:05 ET | [8-K](/filings/0001104659-24-105839.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-105839 |
| 2024-08-13 | 09:22 ET | [10-Q](/filings/0001558370-24-011988.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011988 |
| 2024-08-07 | 16:01 ET | [8-K](/filings/0001104659-24-086740.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086740 |
| 2024-06-18 | 16:15 ET | [8-K](/filings/0001104659-24-072818.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-072818 |
| 2024-06-17 | 08:15 ET | [8-K](/filings/0001104659-24-072044.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-072044 |
| 2024-06-07 | 17:00 ET | [8-K](/filings/0001558370-24-009020.md) | 5.07 Shareholder vote results | 0001558370-24-009020 |
| 2024-05-13 | 17:01 ET | [10-Q](/filings/0001558370-24-007987.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007987 |
| 2024-05-09 | 17:26 ET | [8-K](/filings/0001104659-24-059460.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059460 |
| 2024-04-22 | 16:30 ET | [DEF 14A](/filings/0001104659-24-050024.md) | Proxy statement, period 2024-06-06 | 0001104659-24-050024 |
| 2024-04-01 | 17:00 ET | [8-K](/filings/0001558370-24-004550.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-004550 |
| 2024-03-11 | 09:15 ET | [10-K](/filings/0001558370-24-002864.md) | Annual report, period 2023-12-31 | 0001558370-24-002864 |
| 2024-03-07 | 16:24 ET | [8-K](/filings/0001104659-24-031918.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-031918 |
| 2024-02-02 | 16:30 ET | [8-K](/filings/0001104659-24-010063.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-010063 |

Page 1 of 3. [Older](/companies/elut/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.